At a Glance
| Ephenidine | 3-HO-PCE | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 70–100 mg | 10–15 mg |
| Total Duration | 0.2–0.5 hrs | — |
| Routes | oral | oral |
| Effects | 62 documented | 48 documented |
Ephenidine, a Dissociatives, and 3-HO-PCE, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 32 documented effects in common, with 30 effects unique to Ephenidine and 16 unique to 3-HO-PCE. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Ephenidine | 3-HO-PCE | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 70–100 mg | 10–15 mg |
| Total Duration | 0.2–0.5 hrs | — |
| Routes | oral | oral |
| Effects | 62 documented | 48 documented |
| Interaction |
| Caution |
| Level | Ephenidine | 3-HO-PCE |
|---|---|---|
| Threshold | 30 mg | 5 mg |
| Light | 30–70 mg | 5–10 mg |
| Common | 70–100 mg | 10–15 mg |
| Strong | 100–150 mg | 15–25 mg |
| Heavy | 150 mg | 25 mg |
Ephenidine
3-HO-PCE
Compounding dissociative effects can cause confusion, mania, and loss of motor control